Leveraging a Clinico-Genomic Database to Match Patients to a Trial of Triciribine and Carboplatin: Changing Paradigms in Ovarian Cancer Clinical Research.
Phase of Trial: Phase I/II
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Carboplatin (Primary) ; Triciribine (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 12 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 12 Jan 2018 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2018.
- 06 Aug 2016 Planned number of patients changed from 45 to 36.